labetalol has been researched along with Heart Diseases in 2 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient treated for hypertension with labetalol developed left ventricular failure." | 3.66 | Left ventricular failure with labetalol. ( Bayley, TJ; Frais, MA, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frais, MA | 1 |
| Bayley, TJ | 1 |
| Squire, A | 1 |
| Kupersmith, J | 1 |
1 review available for labetalol and Heart Diseases
| Article | Year |
|---|---|
Beta-adrenergic blocking agents: review and update.
Topics: Adrenergic beta-Antagonists; Heart; Heart Diseases; Heart Rate; Hemodynamics; Humans; Labetalol; Lip | 1985 |
1 other study available for labetalol and Heart Diseases
| Article | Year |
|---|---|
Left ventricular failure with labetalol.
Topics: Adult; Ethanolamines; Heart Diseases; Heart Failure; Humans; Hypertension; Labetalol; Male | 1979 |